Google DeepMind Releases AlphaGenome 2 Genomic AI Model
Google DeepMind announced the release of its genomic AI model, AlphaGenome 2. [[fact:fact-1hbmzzv0b]] The model can predict how DNA sequences and their variants affect specific human cell types and states. [[fact:fact-qlj2j554x]] It takes the target tissue, cell type, or cell state as an input. [[fact:fact-mmvz5vxqp]] Its training data included more than 107 million single-cell atlases from human and mouse samples, spanning 68 tissue types. [[fact:fact-zuf681a7e]] In the TenK10K test covering 28 primary immune cell types, it identified pathogenic causal variants at a rate of 30%, versus 16% for the previous model fine-tuned with single-cell data. [[fact:fact-wkv9jw5f4]] AlphaGenome 2 is available to non-commercial researchers through the AlphaGenome API, but DeepMind says it is for scientific research only and has not been validated or approved for clinical or diagnostic use. [[fact:fact-19jwi4zld]][[fact:fact-zr1x272b2]]